在体外代谢研究α-1,6-葡萄糖化醇糖化物
Ye-Lim Park1, Mi-Sun Lee1, Sung-Hee Park1
1CJ Cheiljedang Research Institute, Suwon, 16495 Republic of Korea.
Food science and biotechnology
|October 20, 2025
概括
新型葡萄糖化醇糖化物 (GSG) 证明了安全的消化. 实验室研究表明,GSG分解为醇,类似于已知的甜剂,支持其在食品和饮料中的使用.
科学领域:
- 食品科学 食品科学 食品科学
- 代谢研究 代谢研究
- 天然甜味剂 天然甜味剂
背景情况:
- 伯托尼 Stevia rebaudiana 提供了一种天然的低热量甜味剂.
- 葡萄糖化醇糖化物 (GSG) 是一种具有增强性质的新型化合物.
- 评估新型食品成分的消化安全性至关重要.
研究的目的:
- 为了评估α-1,6葡萄糖化醇糖化物 (GSG) 的体外消化安全性.
- 为了比较GSG的新陈代谢与常见的醇糖化物 (SG).
主要方法:
- 进行了模拟的胃和肠液测试.
- 厌氧代谢研究使用人类便同质物.
- 分析了GSG和醇糖化物 (SG) 的变化.
主要成果:
- 在模拟的胃和肠液中没有观察到GSG或SG的显著变化.
- 通过无氧代谢与人类便同源物,GSG被完全分解成醇.
- GSG的新陈代谢与常见的SG (如Rebaudioside A和M) 的新陈代谢相当.
结论:
- 在体外消化研究表明,GSG被安全地代谢.
- 消化GSG类似于已建立的草糖化物.
- 结果支持GSG在食品和饮料中的潜在应用.
更多相关视频
13:35Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
921
08:03Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
20.7K
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
522
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
522
Drug Metabolism: Phase II Reactions
4.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.9K
Phase II Reactions: Glucuronidation
1.6K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.6K
